MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

- Featured News and Events -

- GET ANSWERS -

MDS and itching
My husband with MDS (78 with poor prognosis) is having a problem with itching. ...
1 week, 1 day ago
MDS Alternative treatments
I was diagnosed on 6/14 with MDS with MPN overlap. My most recent blood test ...
1 week, 1 day ago
ASXL1 and Vidaza + Decogen
Hi! Thank you to all of you who participate in these forums. You have been a ...
2 weeks, 5 days ago

- GET TREATMENT -

CENTERS OF EXCELLENCE
Would you like your treatment center to become part of the referral system for MDS patients and be designated as a Center of Excellence? To be recognized as a Center of Excellence, an institution must have:
  • An established university (or equivalent) program
  • Recognized morphologic expertise in MDS
  • Available cytogenetics and/or molecular genetics
  • Ongoing research, including Institutional Review Board-approved clinical trials
  • Documentation of peer-reviewed publications in the field
LEARN MORE
CLINICAL TRIALS
Clinical trials study new interventions (drugs or procedures) to evaluate their safety and effectiveness in humans. Trials follow a careful set of steps, allowing for the systematic gathering of information to answer questions and confirm hypotheses that were formed earlier, in either laboratory experiments or preliminary trials. If you are an MDS patient, you may wish to discuss a trial with your primary treating physician to see if you qualify as a candidate. LEARN MORE
 
RECENT NEWS
INSPIRE: Pivotal Trial for Patients with HR-MDS Now Recruiting Patients
INternational Study of Phase III Intravenous RigosErtib STUDY DESCRIPTION A Phase III, international, randomized, controlled study of Rigosertib + LEARN MORE
CELGENE AND ACCELERON ANNOUNCE LUSPATERCEPT ACHIEVED PRIMARY AND KEY SECONDARY ENDPOINTS IN PHASE III ‘MEDALIST’ STUDY IN PATIENTS WITH LOW-TO-INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES
Results showed significant improvement in red blood cell transfusion independence compared to placebo Safety profile generally consistent with LEARN MORE
Upcoming Events
  1. IX International Eurasian Hematology Oncology Congress

    October 17 - October 20
  2. ESMO 2018

    October 19 - October 23
  3. MDS WORLD AWARENESS DAY

    October 25
  4. 11th International Congress on Myeloproliferative Neoplasms

    October 25 - October 26
  5. Pittsburgh MDS Support Group Meeting

    October 25 @ 6:30 pm - 8:00 pm
CONNECT WITH US
Coupon Codes
Use Giving Assistant to save money and support Myelodysplastic Syndromes Foundation

It’s free to help Myelodysplastic Syndromes Foundation when you sign up for Giving Assistant and shop at Bed Bath & Beyond, Aliexpress, and ULTA! Sign up today and get donating!

Review answers to commonly asked questions or get answers to your questions from an MDS expert